The Value of Vaccines to Mitigate Antimicrobial Resistance — Evidence from Low- and Middle-Income Countries

A new report by One Health Trust researchers highlights the importance of boosting vaccination coverage to slow the pace of antimicrobial resistance.

The analysis published with support from the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), focuses on the impact that increasing vaccination coverage would have on the AMR-related health and economic burden in thirteen countries.

AMR develops when microbes evolve and become resistant to current therapies, making infections harder to treat and exacerbating disease spread and severity. The report emphasizes country-specific data to help inform immunization strategies to address AMR in countries facing a high infectious disease burden.